S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

LEGN Legend Biotech Corporation

42.07

-1.06 (-2.46%)

30 Nov 2024 - Closed

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Legend Biotech Charts.

Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Legend Biotech Charts.

Legend Biotech Corporation News

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 15 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 12 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights
Tuesday 12 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
Thursday 7 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 6 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
Wednesday 6 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Legend Biotech Appoints Alan Bash as President of CARVYKTI®
Monday 4 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
Thursday 24 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 22 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 22 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 15 October 2024 (2 months ago) • Edgar (US Regulatory)

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
Thursday 3 October 2024 (2 months ago) • GlobeNewswire Inc.

More Legend Biotech Corporation News Articles

Westpac Banking

JP Morgan Chase

Australia And New Zealan...

National Australia Bank

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions